The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry...

— —

Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry

Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)

$206.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
28 April 2021

Pharmacology; Biotechnology; Artificial intelligence; Expert & knowledge-based systems; Machine learning

The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient’s life.

This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics.

Edited by: Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist AstraZeneca)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 234mm, Width: 191mm,
Weight: 450g
ISBN: 9780128200452
ISBN 10: 0128200456
Pages: 264
Publication Date: 28 April 2021
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

1. Introduction Drug Discovery 2. Intro to ML 3. Data Types 4. Target ID and Val 5. Hit Discovery 6. Lead Optimisation 7. Evaluating Safety and Toxicity 8. Precision Medicine and Finding the 'right patient': Date-driven Identification of Disease Subtypes 9. Image Analysis in Drug Discovery 10. Clinical Trials, Real World Evidence and Digital Medicine 11. To and From the Patient

Dr. Ashenden is Senior Artificial Intelligence and Machine Learning Data Scientist at AstraZeneca, working in the Discovery Sciences, IMed-Biotech Unit. She received her PhD in 2018 from the Department of Chemistry, Cambridge University. Dr. Ashenden has three publications, but in very high impact resources (Methods in Enzymology, Journal of Chemical Information and Modeling, and Journal of Medicinal Chemistry). Dr. Ashenden is a very early career researcher, but has an extensive research network, academic and industrial experience, and a drive to conduct and report high quality research. She will be working with more experienced researchers on the project to help guide and offer experience.